NCT04954235View on ClinicalTrials.gov

Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study

CompletedOBSERVATIONAL
Enrollment

847

Participants

Timeline

Start Date

May 22, 2021

Primary Completion Date

September 9, 2021

Study Completion Date

September 9, 2021

Conditions
Covid19
Trial Locations (1)

Unknown

"Hospital de Campaña Escuela Hogar", Corrientes

Sponsors

Lead Sponsor

Inmunova S.A.
All Listed Sponsors
collaborator

Hospital Italiano de Buenos Aires

OTHER

collaborator

Hospital de Campaña Escuela Hogar

UNKNOWN

collaborator

Laboratorio Elea Phoenix S.A.

INDUSTRY

collaborator

Instituto de Virologia Dr. Jose Maria Vanella

UNKNOWN

lead

Inmunova S.A.

OTHER